2023 Form 5500 filing — Astrazeneca Defined Benefit Pension Plan
Plain-English filing summary
According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, this is the 2023 Form 5500 filing (EFAST2 acknowledgement 20241015113116NAL0029410817001) for Astrazeneca Defined Benefit Pension Plan, reported by Astrazeneca Pharmaceuticals Lp under EIN 23-2967016 and plan number 001. It reports 5,825 participants. Attached schedules in the loaded dataset include Schedule H (large plan financials).
- EFAST2 acknowledgement
- 20241015113116NAL0029410817001
- Filing year
- 2023
- Form type
- 2
- Plan sponsor
- Astrazeneca Pharmaceuticals Lp
- EIN
- 23-2967016
- Plan number
- 001
- Location
- Wilmington, DE
- Participants
- 5,825
- Schedules available
- Schedule H
- Received date
- not reported in the loaded dataset
Reported financial snapshot (2023)
- Total assets (EOY)
- $0
- Total liabilities (EOY)
- $0
- Net assets (EOY)
- $0
- Employer contributions
- $26,800,000
- Total income / additions
- $49,049,000
- Benefits paid
- $879,677,000
- Administrative expenses
- $0
- Total expenses
- $879,677,000
- Net increase / (decrease)
- -$830,628,000
- Schedule source
- Schedule H